Clinical Research Directory
Browse clinical research sites, groups, and studies.
99mTc-QULIC-5-P1 SPECT Imaging in Patients With Prostate Cancer
Sponsor: First Affiliated Hospital of Chongqing Medical University
Summary
99mTc-QULIC-5-P1 is a new radiotracer targeting PSMA, which is promising as an excellent imaging agent applicable to PSMA positive prostate cancer. This study will investigate the safety, biodistribution and potential usefulness of 99mTc-QULIC-5-P1 SPECT imaging for the diagnosis of lesions in PSMA positive prostate cancer.
Official title: 99mTc-QULIC-5-P1 SPECT Imaging in Patients With Prostate Cancer and Compared With 68Ga-PSMA-11 PET
Key Details
Gender
MALE
Age Range
18 Years - Any
Study Type
INTERVENTIONAL
Enrollment
30
Start Date
2024-05-20
Completion Date
2026-12-31
Last Updated
2025-06-04
Healthy Volunteers
Yes
Conditions
Interventions
99mTc-QULIC-5-P1
Each subject receives a single intravenous injection of 99mTc-QULIC-5-P1.
Locations (1)
The First Affiliated Hospital of Chongqing Medical University
Chongqing, Chongqing Municipality, China